Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Heart failure

Room for improvement in UK heart failure care, researchers find

Research has shown that heart failure care in the UK remains suboptimal, despite the implemention of methods to improve patient outcomes.

National reporting and incentive schemes, such as the Quality and Outcomes Framework, introduced in 2004, have not prevented suboptimal management of heart failure in the UK, research published in PLoS Medicine (21 May 2019) has concluded[1].

The researchers examined the electronic health records of 93,074 people who were newly diagnosed with heart failure between 2002 and 2014, including data from both primary and secondary care.

They found that most people (56%) were diagnosed in hospital rather than in primary care, and only 17% of these people had their diagnosis noted in their GP record in the subsequent 12-month period.

Additionally, prescribed doses of angiotensin-converting-enzyme inhibitors/angiotensin receptor blockers, beta-blockers and mineralocorticoid receptor antagonists fell below guideline recommendations, at an average of 42%, 29%, and 22% of the target dose, respectively.

The researchers also noted that gaps in care were more common in women and older people.

While early management of heart failure seemed to have improved, with increased rates of diagnostic testing and treatment initiation over time, the researchers suggested that the broader lack of evidence-based care may be a result of inadequate continuity between primary and secondary care.

“Further improvements are likely to require a broader perspective in health services design to support appropriate care at every level of the patient journey,” they concluded.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2019.20206654

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.